Zevra Therapeutics (ZVRA) Preferred Dividend Payments (2021)
Zevra Therapeutics (ZVRA) posted Preferred Dividend Payments of $16.9 million for Q2 2021, down 54.87% on a QoQ basis from $37.4 million in Q1 2021.
Zevra Therapeutics (ZVRA) Preferred Dividend Payments (2021) Analysis & Trends
Zevra Therapeutics' Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at $16.9 million for Q2 2021.
- Quarterly Preferred Dividend Payments changed N/A year-over-year to $16.9 million in Q2 2021, while the trailing twelve-month figure through Mar 2022 was $16.9 million (down 54.87% YoY) and the FY2021 annual result came in at $54.3 million, changed N/A from the prior year.
- Preferred Dividend Payments was $16.9 million for Q2 2021 at Zevra Therapeutics, down from $37.4 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $37.4 million in Q1 2021 and bottomed at $16.9 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 16.90 Mn |
| Mar 31, 2021 | 37.44 Mn |